Template:Main Page News: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
Line 15: | Line 15: | ||
|- | |- | ||
| | | | ||
:[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#February Gestational Diabetes]] | [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]] | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]] | :[[Template_talk:Main_Page_News|'''Older News Articles''']] - [[Template_talk:Main_Page_News#February|Gestational Diabetes]] | [[Template_talk:Main_Page_News#September|Kyoto eBook]] | [[Template_talk:Main_Page_News#August|Dolly's sisters live on!]] | [[Template_talk:Main_Page_News#June|Thalidomide in Zebrafish]] | [[Template_talk:Main_Page_News#March|Human pancreas stem cells]] | [[Template_talk:Main_Page_News#January|Oral contraceptive no risk of major birth defects]] | [[Template_talk:Main_Page_News#September|Maternal Malaria Neurovascular Development Effects]] | [[Template_talk:Main_Page_News#June|Oocyte/Spermatozoa fate decision]] [[Template_talk:Main_Page_News#April|Rubella eliminated in the Americas]] | [[Template_talk:Main_Page_News#February|Three-person embryos]] | ||
|} | |} |
Revision as of 11:37, 28 July 2017
News - CRISPR Gene Editing |
It has been reported (but not confirmed by publication) that USA scientists have gene-edited embryos using CRISPR. This follows on from an earlier 2015 published work (PMID 25894090) from China using the same technique see Nature 22 April 2015 and a more recent 2017 paper (PMID 28251317).
The CRISPR/Cas9-mediated gene editing system was derived from the adaptive immune system evolved in bacteria to defend against invading plasmids and viruses. |
|